Patents by Inventor William McClements

William McClements has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides for inducing a protective immune response against staphylococcus aureus
    Publication number: 20060177462
    Abstract: The present invention features polypeptides comprising an amino acid sequence structurally related to SEQ ID NO: 1, uses of such polypeptides, and expression systems for producing such polypeptides. SEQ ID NO: 1 is a truncated derivative of a full length <i>S. aureus</i> polypeptide. The full-length polypeptide is referred to herein as full-length “ORF0657n”. Polypeptides containing the amino acid sequence of SEQ ID NO: 1 were found to produce a protective immune response against <i>S. aureus</i>.
    Type: Application
    Filed: July 22, 2004
    Publication date: August 10, 2006
    Inventors: Annaliesa Anderson, Kathrin Jansen, Rosemarie Kelly, Loren Schulz, Donna Montgomery, William McClements
  • Vaccine using papilloma virus e proteins delivered by viral vector
    Publication number: 20050118139
    Abstract: Cell-mediated immune response to a papillomavirus infection can be induced by vaccination with DNA encoding papillomavirus E genes. E genes can both prevent the occurrence of papillomavirus disease, and treat disease states. Canine papillomavirus (COPV) E genes which are codon-optimized to enhance expression in host cells are also given.
    Type: Application
    Filed: August 19, 2002
    Publication date: June 2, 2005
    Inventors: Lingyi Huang, Kathrin Jansen, William McClements, Juanita Monteiro, Loren Schultz, Timothy Tobery, Xin-Min Wang, Ling Chen
  • Synthetic human papilloma virus genes
    Publication number: 20050075303
    Abstract: Synthetic DNA molecules encoding papillomavirus proteins are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against papillomavirus infection through stimulation of neutralizing antibody and cell-mediated immunity.
    Type: Application
    Filed: December 4, 2003
    Publication date: April 7, 2005
    Inventors: Michael Neeper, William McClements, Kathrin Jansen, Loren Schultz, Ling Chen, Xin-Min Wang
  • Synthetic virus-like particles with heterologous epitopes
    Publication number: 20050058988
    Abstract: The invention is a series of synthetic virus-like particles comprising a heterologous conformational epitope useful in the characterization of human papillomavirus infection, and useful to vaccinate individual for protection against HPV 6 and HPV 11 infections, and assays employing the synthetic virus-like particles.
    Type: Application
    Filed: December 16, 2003
    Publication date: March 17, 2005
    Inventors: Kathrin Jansen, Jessica Ling, Steven Ludmerer, William McClements, Xin-Min Wang
  • Novel polymer membranes for reverse osmosis
    Patent number: 3963618
    Abstract: This case is directed to the preparation of polyvinyl acetal resins as semi-permeable membranes for use in the treatment of feed solutions by reverse osmosis, ultafiltration or related techinques.
    Type: Grant
    Filed: July 25, 1974
    Date of Patent: June 15, 1976
    Assignee: Babcock & Wilcox Limited
    Inventor: William McClements Muir